Breaking News

Financial Report: Cambrex 3Q11

Sales were up 18%

Cambrex 3Q11

3Q Revenues: $59.2 million (+24%)

3Q Earnings: $2.8 million (loss of $1.5 million 3Q10)

YTD Revenues: $188.1 million (+16%)

YTD Earnings: $10.2 million (+104%)

Comments: Sales were up 18% in the quarter, excluding a 7% favorable impact of foreign exchange. Growth was primarily due to higher volumes of an API for a customer who experienced a disruption in its supply chain for most of 2010. Increases were partially offset by lower pricing across several product categories, lower sales of generic APIs, and lower custom development shipments.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters